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PCardiac Magnetic Resonance Predicts
Outcome in Patients With Premature Ventricular
Complexes of Left Bundle Branch Block Morphology
Giovanni Donato Aquaro, MD,* Alessandro Pingitore, MD, PHD,† Elisabetta Strata, MD,‡
Gianluca Di Bella, MD, PHD,§ Sabrina Molinaro, PHD,† Massimo Lombardi, MD*
Pisa, Florence, and Messina, Italy
Objectives We investigated whether the presence of right ventricular (RV) abnormalities detected by cardiovascular mag-
netic resonance (CMR) predict adverse outcome in patients presenting with frequent premature ventricular com-
plexes (PVCs) of left bundle branch block (LBBB) morphology.
Background CMR is a component of the diagnostic workup for the differential diagnosis between arrhythmogenic right ven-
tricular cardiomyopathy/dysplasia (ARVC/D) and idiopathic RV tachycardia. RV abnormalities evaluated by CMR
could have prognostic importance.
Methods Four hundred forty consecutive patients with 1,000 PVCs of LBBB morphology (minor diagnostic criterion of
ARVC/D) and no other pre-existing criteria were prospectively enrolled. RV wall motion (WM), signal abnormali-
ties, dilation, and reduced ejection fraction evaluated by CMR were considered imaging criteria of ARVC/D.
Follow-up was performed evaluating an index composite end point of 3 cardiac events: cardiac death, resusci-
tated cardiac arrest, and appropriate implantable cardiac-defibrillator shock.
Results Subjects with multiple RV abnormalities (RVA-2 group) had worse outcome than the no-RVA group (hazard ratio
[HR]: 48.6; 95% confidence interval [CI]: 6.1 to 384.8; p  0.001). Of the 61 patients in the RVA-2 group, only
6 had a definite diagnosis of ARVC/D applying the Task Force Criteria. Also, subjects with a single imaging crite-
rion (RVA-1 group) had worse outcome than the no-RVA group (HR: 18.2; 95% CI: 2.0 to 162.6; p  0.01). Pa-
tients with only WM abnormalities had higher prevalence of cardiac events than no-RVA (HR: 27.2; 95% CI: 3.0
to 244.0; p  0.03).
Conclusions In subjects with frequent PVC of LBBB morphology, CMR allows risk stratification. RV abnormalities were associ-
ated with worse outcome. (J Am Coll Cardiol 2010;56:1235–43) © 2010 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.03.087p
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aremature ventricular complexes (PVCs) of left bundle
ranch block (LBBB) morphology and inferior axis arise
rom the right ventricular (RV) outflow tract or, less
requently, from the higher portion of the interventricular
eptum. PVCs of such morphology constitute a manifestation
f idiopathic right ventricular tachycardia (IRVT) or an initial
rrhythmic manifestation of arrhythmogenic RV cardiomyop-
thy/dysplasia (ARVC/D) (1–3). These 2 diseases initially
ave similar manifestations but are completely opposite in
erms of the prognosis (4–6). IVRT is a disease with excellent
rom *Fondazione G.Monasterio CNR-Regione Toscana, Pisa, Italy; †Institute of
linical Physiology, CNR, Pisa, Italy; ‡Cardiovascular Department, University
f Florence, Florence, Italy; and the §Clinical and Experimental Department of
edicine and Pharmacology, University of Messina, Messina, Italy. The authors have
eported that they have no relationships to disclose.p
Manuscript received January 22, 2010; revised manuscript received February 19,
010, accepted March 10, 2010.rognosis, whereas ARVC/D is characterized by a great risk of
udden cardiac death, especially in young people involved in
ompetitive sports (7). In Italy, where this study was con-
ucted, ARVC/D has high incidence and is one the major
See page 1244
auses of sudden death in the young (8). The diagnosis of
RVC/D is based on the presence of concomitant major
nd minor signs: functional and morphological abnormali-
ies of the RV, electrocardiographic abnormalities, arrhyth-
ias, and family history (9,10). Cardiac magnetic resonance
CMR) has been proposed as a valuable component of the
iagnostic workup for ARVC/D (11). CMR frequently
hows only minimal morphological and functional alter-
tions that are not sufficient to diagnose ARVC/D. In the
resent study, we enrolled a selected group of subjects who
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CMR and Outcome of Patients With Frequent PVCs October 5, 2010:1235–43only had a history of PVCs, with-
out other clinical, electrocardio-
graphic, and echocardiographic
criteria associated with ARVC/D.
The aims of the study was to
evaluate the relationship between
RV abnormalities detected by
CMR and the clinical end points
of cardiac death, resuscitated car-
diac arrest, and appropriate im-
plantable cardiac-defibrillator
(ICD) shock using a long-term
follow-up.
Methods
Study population. Four hun-
dred forty consecutive subjects
with frequent PVCs of LBBB
morphology and inferior axis on
referring clinical exam of CMR
from January 2002 to March
2005 were prospectively enrolled.
In order to select patients with
minimal confounding factors,
the following inclusion criteria
were applied: 1) 1,000 or more
PVCs of LBBB morphology and
inferior axis on 24-h Holter elec-
trocardiogram (ECG) monitor-
ing; 2) normal resting echocar-
iogram; 3) maximal exercise test negative for ischemia; 4)
ormal 12-lead rest electrocardiogram; 5) no familial history
f sudden death; 6) no history of coronary artery disease,
ardiomyopathy, systemic hypertension, or diabetes melli-
us; and 7) absence of contraindications to CMR.
Patients with frequent PVCs or ventricular bigeminism
uring examination were treated with an oral antiarrhyth-
ic agent (propafenone, flecainide, or amiodarone) for 1
eek before CMR examination in order to optimize ECG
rigger and to obtain optimal image acquisition.
Of the initial study population, 44 subjects were excluded
or claustrophobia (n  18), body dimension above the
canner diameter (n  5), and very frequent PVCs despite
ntiarrhythmic drugs during CMR (n 21). Thus, the final
opulation included 396 patients (mean age 33 years, 257
ales).
MR. CMR examination was performed using a 1.5-T
igna CVi scanner (GE, Milwaukee, Wisconsin) with a
ardiac phased-array 8-channel coil. For the assessment of
egional wall motion (WM) and left ventricular (LV) and
V volumes and mass, cine images were used with a
teady-state free precession (Fast Imaging Employing
teady-State Acquisition [FIESTA]) pulse sequence in
hort-axis views (from atrioventricular valve plane to the
Abbreviations
and Acronyms
ARVC/D  arrhythmogenic
right ventricular
cardiomyopathy/dysplasia
CI  confidence interval
CMR  cardiovascular
magnetic resonance
ECG  electrocardiogram
HR  hazard ratio
ICD  implantable
cardiac-defibrillator
IRVT  idiopathic right
ventricular tachycardia
LBBB  left bundle
branch block
LV  left
ventricle/ventricular
NYHA  New York Heart
Association
PVC  premature
ventricular complex
RV  right
ventricle/ventricular
RVA  right ventricular
abnormalities
VT  ventricular
tachycardia
WM  wall motionpex, 8-mm slice thickness, no gap) and in para-axial views ifrom diaphragm to the entire outflow tract, 5-mm slice
hickness, no gap). The following acquisition parameters
ere applied: 30 phases, 10 to 25 views per segment
epending on heart rate, NEX 1, FOV 40 cm, a matrix of
24  224, a 45° flip angle, TR/TE equal to 3.5/1.5, and a
andwidth of 125 kHz.
For the evaluation of fat infiltration, a fast spin echo
mage was acquired in the same short-axis view (8-mm slice
hickness, no gap) and para-axial view (5-mm slice thick-
ess, no gap) with the following parameters: NEX 1, FOV
0 cm, matrix of 256  256, a 90° flip angle, TR/TE of
,791/41.5, and a bandwidth of 62.5 kHz. Fast spin echo
mages were also reacquired using a fat saturation pulse to
electively null signals from fat.
ost-processing. Using dedicated software (Mass Analy-
is, MEDIS, Leiden, the Netherlands), the following func-
ional parameters were obtained from the short-axis images:
V and LV end-diastolic volume index, RV and LV
nd-systolic volume indexes, LV mass index, and RV and
V ejection fraction. The RV and LV volume indexes were
ompared with the respective reference values clustered for
lass age and sex (12,13). RV WM was evaluated by 2
ndependent expert investigators (G.D.A. and E.S.) from
he short-axis and para-axial cine views and were classified
s normal WM, minor WM abnormalities (hypokinetic
egment), or major WM abnormalities (akinetic or bulging
egment) (Fig. 1).
Similarly, fast spin echo images with and without fat
aturation were evaluated by 2 independent expert investi-
ators, and the signal from the RV wall was classified as
ollows: 1) normal signal if there was no evidence of
yperintense myocardium with infiltrative characteristics; or
) signal alteration (myocardial area hyperintense in fast
pin echo images and hypointense in fat saturation fast spin
cho images) diffuse (more than 1 segment) if focal, but
nfiltrating or associated with wall thinning (Fig. 2).
Any discrepancies between the investigators were then
ndependently adjudicated by a blinded third investigator
M.L).
roup definition. According to the Task Force diagnostic
riteria for ARVC/D, CMR findings accepted as major
iagnostic criteria are severe WM abnormalities (akinesia,
ulging) and severe RV dilation with dysfunction (defined
s mean end-diastolic volume index 4 SD above the mean
eference value, and RV ejection fraction lower than 40%)
10). Minor CMR diagnostic criteria of ARVC/D are: mild
M abnormalities (hypokinesia), mild RV dilation defined
s mean end-diastolic volume index 2 and 4 SD about
he mean of the reference, or RV ejection fraction between
0% and 50%). Considering that all patients were positive
or only a minor criterion (1,000 PVCs in 24 h with
BBB morphology and inferior axis), the diagnosis of
RVC/D was based on the evidences of major or minor
MR criteria for ARVC/D. Therefore, on the basis of the
resence or absence of these criteria, subjects were clustered
n 2 groups: no-RVA group (patients without RV abnor-
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October 5, 2010:1235–43 CMR and Outcome of Patients With Frequent PVCsalities found by CMR) and RVA group (patients with the
resence of 1 or more RV abnormalities). RVA group was
lso subdivided into 2 groups: RVA-1 (patients with only 1
V abnormality) and RVA-2 (patients with 2 or more RV
bnormalities). Signal alteration of the RV wall that is not
ncompassed in the Task Force Criteria, but is considered
s an imaging equivalent of fat infiltration at biopsy, was
lso assumed to be a major criterion but not sufficient to
ulfill a definite diagnosis of ARVC/D.
linical follow-up. Follow-up was performed in all pa-
ients for a mean of 1,348  120 days after the CMR
xamination. A clinical questionnaire was compiled by a
linical physician during periodic ambulatory visitations in
ur institute (93 patients, 23.5%) or telephone contact (303
atients, 76.5%). The clinical questionnaire included the
efinition of the major end points: cardiac death, resusci-
ated cardiac arrest, and appropriate ICD shock.
ICD shocks were designated appropriate if triggered by
ethal arrhythmias: ventricular tachycardia above the pro-
rammed cutoff of the ICD (12 intervals at 180 beats/
in), or ventricular fibrillation. A complete interrogation of
he ICD was performed by the referring physician in order
Figure 1 Wall Motion Abnormalities
The upper panels show basal end-diastolic (A) and end-systolic (B) short-axis view im
In the lower panels, end-diastolic (C) and end-systolic (D) long-axis view images co confirm the appropriateness of the shock. Furthermore, ahe following data were obtained: New York Heart Asso-
iation (NYHA) functional class, cardiac hospitalization, a
iagnostic test for diagnosis of ARVC/D (electrophysiolog-
cal test, myocardial biopsy, late potential monitoring),
evice therapy (ICD, pacemaker), and pharmacologic ther-
py. At the electrophysiological test, ventricular tachycardia
VT) was considered inducible if programmed electrical
timulation or isoproterenol infusion initiated sustained VT
hat replicated the morphology of the spontaneous PVCs.
entricular extrastimuli were introduced at the RV apex and
epeated at the RV outflow tract. A copy of the clinical
eport was obtained from the referring physician when
vents occurred.
tatistical analysis. Categorical variables were expressed as
ercentages. The continuous variables having a normal
istribution were expressed as mean values, accompanied by
heir standard deviation. All continuous variables having a
on-normal distribution were expressed as median values,
ccompanied by their relative 25th and 75th quartiles.
omparisons between groups were made with the chi-
quare test with Yates correction and t test or Mann-
hitney U test, where appropriate. Logistic regression
at provide evidence of bulging in the basal right ventricular free wall (arrow).
the presence of systolic bulging (arrow).ages th
onfirmnalysis was carried out for the hazard risk evaluation of VT
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CMR and Outcome of Patients With Frequent PVCs October 5, 2010:1235–43t 24-h ECG Holter monitoring as the dependent variable
nd age, sex, and the different groups of patients with any
V wall abnormality versus the group without any RV wall
bnormality at imaging criteria as independent variables in
he model. Kaplan-Meier survival curves (14) were con-
tructed to compare the occurrence of major cardiac events
mong the RVA and no-RVA groups, with differences in
urvival curves assessed through the log-rank test. Cox
roportional hazards regression analysis was carried out for
he risk evaluation of major cardiac events using a fixed
odel with cardiac event as the dependent variable and
VA groups as independent variables. Cox univariate re-
ression analysis was used to explore each variable in a
odel with cardiac event as the dependent and signal
lteration, WM abnormalities, LV mass index, RV end-
iastolic volume index, RV end-systolic volume index, RV
jection fraction, RV end-diastolic diameter, and RV end-
ystolic diameter as independent predictors.
Statistical analyses were performed using SPSS version 13
SPSS Inc., Chicago, Illinois), and a p value 0.05 was
onsidered significant.
esults
ll of the 396 patients completed the CMR protocol
ithout major complications. In 21 patients, the examina-
ion was repeated after pre-medication with antiarrhythmic
rugs because of arrhythmic interference. A third investi-
ator was used to adjudicate the discrepancies in image
nterpretation that occurred in 25 patients.
MR results. As shown in Table 1, 126 subjects (31.8%)
ad RV abnormalities (RVA group). Of these, 61 subjects
Figure 2 Signal Alteration of Right Ventricular Wall
The upper panels show 3 T1-weighted fast spin echo images in long-axis views (A
applying the fat saturation pulse (D and E). The red and green quadrants show th
wall signal alteration shows evidence compatible with fat infiltration; the green qu15.4%) were included in RVA-2 and 65 (16.4%) in the
eVA-1 group. The remaining 270 subjects (68.2%) were
ncluded in the no-RVA group. Of the 61 patients in the
VA-2 group, 6 patients had WM abnormalities (akinesia/
ulging) as major criteria plus 2 minor criteria (mild-to-
oderate RV dilation and frequent PVCs), allowing a
efinite diagnosis of ARVC/D by applying the Task Force
riteria, whereas in the remaining 55, the presence of signal
The lower panels show the 3 images acquired in the same long-axis projection
rgement of 2 regions of the image in B: the red quadrant right ventricular
shows fat infiltration in the left ventricular wall.
iagnostic Criteria AfterMR Examina ion in This PopulationTable 1 Diag ostic Criteria AfterCMR Examination in This Population
Criteria* Criteria, n Patients, n (%)
PVC 1 minor 270 (68.2)
PVC and mild RV dilation 2 minor 1 (0.25)
PVC and severe RV dilation 1 major 1 minor 1 (0.25)
PVC and fat infiltration 1 major 1 minor 22 (5.6)
PVC and fat infiltration and mild RV dilation 1 major 2 minor 3 (0.8)
PVC and minor WM 2 minor 16 (4)
PVC and minor WM and mild RV dilation 3 minor 2 (0.5)
PVC and major WM 1 major 1 minor 25 (6.3)
PVC and major WM and mild RV dilation 1 major 2 minor† 2 (0.5)
PVC and major WM and severe RV dilation 2 major 1 minor† 1 (0.25)
PVC and fat infiltration and minor WM 1 major 2 minor 11 (3)
PVC and fat infiltration and minor WM and
mild RV dilation
1 major 3 minor† 1 (0.25)
PVC and fat infiltration and major WM 2 major 1 minor† 38 (9.6)
PVC and fat infiltration and minor WM and
severe RV dilation
2 major 2 minor 1 (0.25)
PVC and fat infiltration and major WM and
mild RV dilation
2 major 2 minor† 2 (0.5)
PVC indicates premature ventricular complexes (1,000 in 24 h) of typical morphology and axis;
inor WM indicates a minor wall motion abnormality (hypokinesia); and major WM indicates a
ajor wall motion abnormality (akinesia, bulging). Signal alteration was assumed as an equivalent
f fat infiltration. †Six patients had a definite diagnosis of arrhythmogenic right ventricular
ardiomyopathy/dysplasia (ARVD/C) using the Task Force Criteria (fat infiltration at CMRto C).
e enla
adrantxcluded).
CMR  cardiac magnetic resonance; RV  right ventricle.
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October 5, 2010:1235–43 CMR and Outcome of Patients With Frequent PVCslterations as only a surrogate major criterion (fat infiltra-
ion) plus at least 2 minor criteria did not allow a definite
iagnosis. Of the RVA-1 group, 22 subjects (5.6%) had only
ignal alterations; 43 (10.8%) had only WM abnormalities.
All patients had normal global and regional LV function.
hree patients showed signal alterations compatible with fat
nfiltration in LV myocardium: 1 in the interventricular
eptum, 2 in the inferolateral wall. All of them also showed
V WM abnormalities combined with RV signal alteration
nd were included in the RVA-2 group.
LV and RV functional parameters are reported in Table 2.
he RVA group had significantly higher RV volumes than
he no-RVA patients, whereas LV volumes were not dif-
erent between those groups.
linical data. During the follow-up in 6 patients, an
lternative diagnosis was performed: 4 in patients with
ormal CMR examination (1 coronary heart disease and
ulmonary cancer, 1 Brugada syndrome, 1 long-QT syn-
rome, 1 accessory pathways); and 2 in patients with WM
bnormalities of the RV wall (1 sarcoidosis and 1 pulmonary
ypertension). These patients were excluded from the anal-
sis of the follow-up data.
unctional Parameters of LV and RVTable 2 Functional Parameters of LV and RV
Variable* RVA No-RVA p Value
n 126 270
Male (%) 86 (68.3) 170 (63) 0.3
Age (yrs) 34 17 32 16 0.5
RV ejection fraction, % 59 10 60 7 0.51
RV EDVi, ml/m2 89 25 78 16 0.001
RV ESVi, ml/m2 38 20 31 9 0.001
LV ejection fraction, % 60 8 62 6 0.08
LV EDVi, ml/m2 87 18 85 17 0.33
LV ESVi, ml/m2 35 12 33 10 0.09
LV mass index, g/m2 74 18 71 14 0.11
RVA indicates the group of patients with any RV wall abnormalities; no-RVA indicates the group
ithout any RV wall abnormalities and imaging criteria.
EDVi  end-diastolic volume index; ESVi end-systolic volume index; LV  left ventricle/
entricular; RV  right ventricle/ventricular.
Incidence of VT at 24-h ECG Holter MonitoringTable 3 Incidence of VT at 24-h ECG Holter
Group* n (%) O
Global population 396
No-RVA (no imaging criteria) 270 (68.2)
RVA 126 (31.8)
RVA-1 65 (16.4)
Signal alteration alone 22 (5.6)
WM abnormalities alone 43 (10.8)
RVA-2 61 (15.4)
The logistic regression model is calculated using only 3 factors (age, s
at 24-h ECG Holter monitoring. *RVA indicates the groups of patients w
abnormalities and imaging criteria; RVA-1 indicates the group of patie
abnormalities; signal alteration alone indicates patients with only R
indicates patients with only WM abnormalities. †Significance values refer to
CI  confidence interval; ECG  electrocardiogram; OR  odds ratio; WMNonsignificant differences between the no-RVA and
VA groups were found using the 24-h Holter ECG
onitoring with regards to the number of PVCs, couplets,
riplets, and episodes of ventricular bigeminism. In 78
ubjects (19.7%), episodes of VT were recorded, mostly
96%) nonsustained VT. In Table 3, the relative incidence
f VT is shown for the groups of the population. The
ccurrence of VT was higher in patients with RV abnor-
alities compared with the no-RVA group.
Eleven patients were in NYHA functional class II with
o significant difference between groups; the remaining
ere in NYHA functional class I.
An electrophysiological test was performed in 32 patients
ith nonsustained VT: 15 patients of the RVA-2 group (4
ositive for inducible VT), in 12 patients in the RVA-1
roup (3 positive for inducible VT), and in 5 patients in the
o-RVA group (3 positive for inducible VT). Endomyocar-
ial biopsy was performed in 1 patient of the RVA-2 group,
onfirming the presence of fat infiltration.
Following CMR examination and subsequent clinical
ests, an ICD was implanted in 1 patient with no RV
bnormalities because of the occurrence of 2 episodes of
yncope triggered by sustained VT and a positive electro-
hysiological test. ICDs were implanted in 2 patients in the
VA-1 group (2 of the 3 patients with inducible VT at
lectrophysiologic test), and in 9 patients in the RVA-2
roup (4 with inducible VT, 1 with biopsy-proven fat
nfiltration, 4 with RV wall abnormalities and severe RV
ilation).
linical end points. In the follow-up, 14 major cardiac
vents occurred: 3 sudden cardiac deaths; 9 appropriate ICD
hocks, and 2 resuscitated cardiac arrests. One more subject
n the no-RVA patient group died from pulmonary cancer
nd was excluded from the analysis. Of the 14 major cardiac
vents, 1 event (appropriate ICD shock) occurred in the
o-RVA group, whereas 13 occurred in the RVA group
Table 4).
The occurrence of a cardiac event was significantly higher
n the RVA group than in the no-RVA group (hazard ratio
itoring
nce of VT
Other Groups vs. No-RVA Group†
OR 95% CI p Value
(19.7) — — —
(11.5) — — —
(37.3) 2.3 1.4–3.8 0.001
(31.7) 1.6 0.8–2.9 0.17
(29.1) 1.3 0.4–3.3 0.69
(41.8) 1.8 0.8–3.7 0.14
(44.3) 3.5 1.9–6.6 0.001
RVA groups) to predict the occurrence of ventricular tachycardia (VT)
RV wall abnormalities; no-RVA indicates the group without any RV wall
single RV abnormalities; RVA-2 indicates the group with combined RV
l alteration (equivalent of fat infiltration); WM abnormalities aloneMon
ccurre
78
32
46
19
6
13
27
ex, and
ith any
nt with
V signaa comparison of the relevant group to the no-RVA group.
 wall motion.
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CMR and Outcome of Patients With Frequent PVCs October 5, 2010:1235–43HR]: 32.0; 95% confidence interval [CI]: 4.2 to 244.8; p
.001). Event-free survival curves for these 2 groups are
hown in Figure 3. Both the RVA-2 (HR: 48.6; 95% CI:
.1 to 384.8; p  0.001) and the RVA-1 groups (HR: 18.2;
5% CI: 2.0 to 162.6; p  0.01) had more cardiac events
nd a worse survival curve than the no-RVA group (Fig. 4).
No events occurred in patients included in the RVA-1
roup presenting with only signal alteration. Compared
ith the no-RVA group, patients in RVA-1 with only WM
bnormalities had a significantly higher incidence of cardiac
vents (4 events, HR: 27.2; 95% CI: 3.0 to 244.0; p 0.03).
hen only sudden cardiac deaths and resuscitated cardiac
rrests were considered, all 5 events occurred in the 126
ubjects of the RVA group versus 270 cases of no-RVA
chi-square corrected test: 7.9; p  0.005).
End Points Occurrence in GroupsTable 4 End Points Occurrence in Groups
Groups* n (%) SCD Aborte
Global population 396 3 2
No-RVA 270 (68.2) 0 0
RVA 126 (31.8) 3 2
RVA-1 65 (15.4) 1 2
Signal alteration alone 22 (5.5) 0 0
WM abnormalities alone 43 (10.8) 1 2
RVA-2 61 (16.4) 2 0
*RVA indicates the groups of patients with any RV wall abnormalities; n
the group of patient with single RV abnormalities; and RVA-2 indicate
patients with only RV signal alteration (equivalent of fat infiltration)
ICD-firing indicates an appropriate ICD shock. The Cox proportional ha
variable and RVA groups as independent variables. †Significance valu
not adjusted for sex and age.
CA  cardiac arrest; SCD sudden cardiac death; other abbreviatio
Figure 3 Kaplan-Meier Survival Curves
of the RVA Versus No-RVA Groups
Comparison of the event-free (sudden cardiac death, resuscitated sudden
death, appropriate ICD shock) survival curve of the RVA and no-RVA groups,
showing a significant worse outcome for the patients in the RVA group. ICD 
implantable cardiac-defibrillator; no-RVA  no right ventricular abnormalities;
RVA  right ventricular abnormalities.In the RVA-2 group, 3 of the 6 patients with a definite
iagnosis of ARVC/D by Task Force Criteria had events,
hereas 6 events were found in the remaining 56 patients
ithout a definite diagnosis.
No cardiac events were recorded in patients younger than
0 years of age. Three cardiac events were recorded in
atients between 20 and 35 years of age, 3 in patients
etween 35 and 47 years of age, and 8 in patients older than
7 years of age. Ten cardiac events were recorded in male
atients and 4 in female.
Table 5 shows the results of the univariate analysis used in
model with cardiac event as the dependent variable and
ignal alteration, WM abnormalities, LV mass index, RV
nd-diastolic volume index, RV end-systolic volume index,
V ejection fraction, RV end-diastolic diameter, and RV
nd-systolic diameter as independent variables.
d Points Other Groups vs. No-RVA†
ICD Firing Combined HR 95% CI p Value
9 14 — — —
1 1 — — —
8 13 32.0 4.2–244.8 0.001
1 4 18.2 2.0–162.6 0.01
0 0 — — —
1 4 27.2 3.0–244.0 0.03
7 9 48.6 6.1–384.8 0.001
ndicates the group without any RV wall abnormalities; RVA-1 indicates
oup with multiple RV abnormalities; signal alteration alone indicates
bnormalities alone indicates patients with only WM abnormalities;
ression was calculated using combined end points as the dependent
r to a comparison of the relevant group to the no-RVA group. HR was
n Table 3.
Figure 4 Kaplan-Meier Survival Curves of All Groups
Comparison of the event-free survival curve of the no-RVA, RVA-1, and RVA-2
groups. Both the RVA-2 group as well as the RVA-1 group had significantly
worse outcome than the no-RVA group. ARVC/D  arrhythmogenic right ventric-
ular cardiomyopathy/dysplasia; other abbreviations as in Figure 3.En
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October 5, 2010:1235–43 CMR and Outcome of Patients With Frequent PVCsiscussion
he findings of the present study show that patients with
requent PVCs of LBBB morphology and inferior axis and
o other pre-existing diagnostic criteria for ARVC/D can
e distinguished, according to the presence of CMR mor-
hological and/or functional RV abnormalities, in 3 groups
ith different outcome: those having no RV abnormalities,
VA-1 having single RV abnormalities, and RVA-2 having
everal RV abnormalities.
Our study population was carefully selected and was
omposed of patients with normal basal echocardiograms,
ithout electrocardiogram alterations, negative exercise
ests, and without family history of ARVC/D or sudden
eath. Moreover, we excluded patients that met the criteria
or ARVC/D other than frequent PVCs arising from the
V (minor diagnostic criteria). Indeed, the results showed
hat patients with multiple RV abnormalities (RVA-2) had
worse event-free survival curve and higher incidence of
ombined end point (sudden cardiac death, resuscitated
ardiac arrest, appropriate ICD shock) than those without
ny RV abnormalities (i.e., IRVT subjects). Interestingly,
ubjects in the “gray zone” (RVA-1, 16.4%) had a higher
ncidence of cardiac events and a worse survival curve than
he no-RVA group.
In this study, we assumed the signal alteration found by
MR as an imaging equivalent of fat infiltration. This
ssumption could be not correct for the diagnosis of
RVC/D applying the Task Force Criteria where fat
nfiltration is considered a major criterion only when con-
rmed at biopsy. Thus, as evidenced in Table 1, using the
ask Force Criteria, only 6 patients had a definite diagnosis
f ARVC/D, whereas in 55, CMR raised the suspicion of
his disease for the presence of multiple abnormalities but
ithout giving a definite diagnosis.
However, this evidence reinforced the results of our
tudy: morphofunctional abnormalities found by CMR were
elated to prognosis even when not sufficient to make a
iagnosis of ARVC/D.
These results confirm the key role of CMR in the
Hazard Univariate on Prediction of End PointsTable 5 Hazard Univariate on Prediction of E
Variable Overall (n  396) En
Signal alteration (yes) 83
WM abnormalities (yes) 104
LV mass index, g/m2 72 16
RV EDVi, ml/m2 83 21
RV ESVi, ml/m2 34 15
RV EF, % 60 9
RV EDD, mm 39 8
RV ESD, mm 27 7
The Cox univariate proportional-hazards regression was calculated u
specified in the table as independent variables. HR was not adjusted
EDD  end-diastolic diameter; EF  ejection fraction; ESD  end-sssessment of RV function and morphology, highlighting ehe potential of this technique in stratifying subjects at low
rrhythmic risk according to the evidence of RV morpho-
ogical and functional abnormalities. These results are in
greement with a previous study showing that RV abnor-
alities detected by CMR constitute a source of malignant
entricular arrhythmias in the absence of a definite diagnosis
f ARVC/D (15). Regarding IRVT, there are discordant
esults on the presence of RV abnormalities (16–18). Some
tudies showed CMR signal alterations in patients with
RVT (18); other studies showed only minimal WM
bnormalities without signal alterations (17), whereas others
id not show any kind of RV abnormalities (19,20). The
easons of these discordances may be linked to the selection
riteria of subjects. In the case of our study, we adopted a
trict selection criteria through which only subjects with
requent PVCs, normal echocardiography, normal ECGs,
nd no other criteria for ARVC/D were included, and
efined IRVT subjects as those without RV abnormalities.
When we investigated the impact of the different RV
bnormalities on the prognosis, no cardiac event occurred in
he group of patients with fat infiltration and normal WM.
his finding agrees with the results of Gaita et al. (4),
howing excellent long-term prognosis in subjects with
bnormal RV signals only. In contrast, patients with WM
bnormalities alone had a significantly higher incidence of
nd points than the no-RVA group and a similar event-free
urvival curve to that observed in patients with combined
bnormalities.
One other important finding was that no cardiac events
ere recorded in the group of patients younger than 20 years
f age. In contrast, the groups containing older RVA
atients showed a higher incidence of combined end points.
hese results could be explained by the fact that ARVC/D
s an evolving disease that usually begins to manifest after 20
ears of age (5). Keller et al. (21) also showed a similar result
egarding a higher incidence of arrhythmic events in a small
opulation of patients with RV abnormalities.
tudy limitations. A limitation of the study was the low
revalence of cardiac events in the follow-up. This was
oints
t (n  14)
Univariate
HR 95% CI p Value
9 7.9 2.60–23.8 0.001
13 42.0 5.50–321.2 0.001
 17 1.03 1.01–1.06 0.023
 49 1.04 1.02–1.06 0.001
 48 1.03 1.02–1.09 0.001
 15 0.09 0.86–0.97 0.004
 10 1.1 1.03–1.20 0.005
 8 1.1 1.01–1.20 0.04
mbined cardiac event as the dependent variable and the variables
and age.
iameter; other abbreviations as in Tables 1 to 4.nd P
d Poin
83
110
48
53
46
34
sing coxpected, considering the low risk for cardiovascular events
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CMR and Outcome of Patients With Frequent PVCs October 5, 2010:1235–43f the enrolled subjects, for the middle young age, and the
bsence of signs or symptoms of cardiac disease.
Further studies are needed to evaluate the prognostic
tility of the single RV abnormalities (WM abnormalities,
all signal alteration, RV dilation, and decreased function)
s predictors of cardiac events.
Another limitation of this study is that only a minority of
ur population underwent an electrophysiological study
uring follow-up. The electrophysiological study was dem-
nstrated to be useful for the differential diagnosis between
RVC/D and IRVT due to different arrhythmic mecha-
isms in these 2 diseases (15). However, patients at the
oment of the enrollment had low arrhythmic risk, all of
hem presenting frequent PVCs only. Thus, in this popu-
ation, invasive assessment was not justified. Furthermore,
revious studies showed a good correlation between the site
f wall abnormalities found by CMR and electroanatomic
apping (22–24). Another limitation was the lack of
valuation of fibrosis using a delayed enhancement tech-
ique that could assess the fibro-fatty variant of ARVC/D
25). However, the great difference in prognosis between the
roup of patients with and without RV wall abnormalities in
his study could justify the avoidance of contrast media
njection in this group of selected patients at low risk.
otwithstanding, a delayed enhancement technique could
robably improve the accuracy of diagnosis. In fact, in the
uture, myocardial fibrosis could be considered as an adjunc-
ive imaging criteria, potentially shifting patients from the
ntermediate group to the ARVC/D group or excluding
lternative diagnoses such as coronary artery disease or a
ifferent cardiomyopathy.
Finally, this study was performed in Italy, where a higher
ncidence of ARVC/D, especially in the Veneto region, has
een demonstrated, and young people must undergo a strict
edical selection in order to participate in competitive
ports (9). Studies performed in other regions may provide
ifferent results in terms of the incidence of disease and the
rognosis.
onclusions
atients with frequent PVC of LBBB morphology and
nferior axis and no other pre-existing diagnostic criteria for
RVC/D have been distinguished in 3 different groups
ccording to the presence of RV abnormalities at CMR: at
ne extreme, IRVT subjects having excellent prognosis, at
he other extreme, ARVD/C subjects having worse prog-
osis, and in the middle grey zone, subjects having few RV
bnormalities and intermediate prognosis. Patients with
M abnormalities alone had significantly higher preva-
ence of the combined end points, whereas RV signal
lteration alone was not associated with a worse prognosis
han in the no-RVA patients. Finally, the incidence of
ardiac events increased with age and was absent in patients
ounger than 20 years of age.eprint requests and correspondence: Dr. Giovanni Donato
quaro, Gabriele Monasterio CNR-Tuscany Foundation, Via
onato 1, 56124 Pisa, Italy. E-mail: aquaro@ifc.cnr.it.
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